Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether she plans to increase funding for biomedical research on long covid.

For long COVID, research and scientific evidence is pivotal in shaping our understanding of causes and effects for individuals and the population. Over £50 million has already been invested in long COVID research projects to improve our understanding of the diagnosis and underlying mechanisms of the disease and the effectiveness of both pharmacological and non-pharmacological therapies and interventions, as well as to evaluate clinical care.

The Department funds research through the National Institute for Health and Care Research (NIHR). The NIHR welcomes funding applications for research into any aspect of human health, including long COVID. The Medical Research Council also funds biomedical research into long COVID. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards being made based on the importance of the topic to patients and health and care services, value for money and scientific quality. In all disease areas, the amount of NIHR funding depends on the volume and quality of scientific activity.